Management tracks: RegenxBio, Verrica, Reagan-Udall Foundation

Gene therapy company RegenxBio Inc. (NASDAQ:RGNX) hired Steve Pakola as SVP and CMO. Pakola was CMO at Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO).

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) terminated the employment of COO Linda Palczuk, effective April 22. In an SEC filing, the dermatology company said it will no longer staff the position. Palczuk joined the company in February 2018. Verrica plans to submit an NDA to FDA next half for for VP-102 to treat molluscum contagiosum (see "Verrica to Submit NDA for Contagious Skin Disease Therapy")...